Displaying 1361 - 1380 of 2227
Steris/Synergy Health, In the Matter of
The FTC issued an administrative complaint charging that Steris Corporation’s proposed $1.9 billion acquisition of Synergy Health plc would violate the antitrust laws by significantly reducing future competition in regional markets for sterilization of products using radiation, particularly gamma or x-ray radiation. The Commission also authorized agency staff to seek a temporary restraining order and preliminary injunction in federal court to maintain the status quo pending an administrative trial on the merits. According to the FTC, it is unlikely that new competitors in the market for contract radiation sterilization services would replicate the competition that would be eliminated by the merger. The Commission alleged that the challenged acquisition would eliminate likely future competition between Steris’s gamma sterilization facilities and Synergy’s planned x-ray sterilization facilities in the United States, thus depriving customers of an alternative sterilization service and additional competition. On September 25, 2015 the district court denied the FTC motion for a PI. On October 30, the Commission dismissed the administrative complaint.
Marketer of Rug Accessory Settles FTC Charges of Invitation to Collude with Competitor
FTC Staff Provides Comments to Pennsylvania General Assembly on Proposals Affecting Pre-Need Cemetery Sales
FTC Approves Final Order Preserving Competition in U.S. Markets for an Inhalation Solution and Three Injectable Products
Two Pennsylvania Orthopedic Practices Settle FTC Charges That Merger Harmed Competition and Inflated Prices
In Comments Submitted to Virginia and Tennessee Health Departments FTC Staff Offers Assistance in Evaluating Proposed Hospital Cooperation Agreements
FTC Chairwoman Ramirez Testifies Before Congress on Legislation That Would Alter the Agency’s Role in Adjudicating Merger Cases
Investor Len Blavatnik to Pay $656,000 to Settle FTC Charges That He Violated U.S. Premerger Notification Requirements
FTC Files Amicus Brief Explaining that Pharmaceutical “Product Hopping” Can Violate the Antitrust Laws
FTC Requires Divestitures Prior to Merger of Orthopedic Device Companies
FTC Approves Application for Modification of Divestiture Agreement Between Albertsons and Haggen Holdings, LLC
FTC Requires Divestitures in Connection with Endo International plc’s Proposed Acquisition of Par Pharmaceuticals, Inc.
In Settlement with FTC, National Association of Animal Breeders Agrees to Eliminate Rules That Limit Competition Among its Members
Leucadia National Corporation to Pay $240,000 to Settle FTC Charges It Violated U.S. Premerger Notification Requirements
FTC Issues Final Order Preserving Competition for Deeply Discounted General Merchandise
FTC Approves Application from ZF Friedrichshafen AG and TRW Automotive Holdings Corp. to Divest TRW’s Linkage and Suspension Business in North America and Europe
Third Point Funds Agree to Settle FTC Charges that They Violated U.S. Premerger Notification Requirements
Displaying 1361 - 1380 of 2227